Rachel Sherman

Dr. Rachel Sherman is the former Principal Deputy Commissioner of the U.S. Food and Drug Administration, where she served as the Commissioner’s most senior policy advisor and held the highest non-politically appointed position at the agency. With nearly thirty years at the FDA, she brings unparalleled expertise in medical product regulation, drug development policy, and healthcare innovation to every keynote.

Shaping the Future of American Healthcare

During her FDA career, Sherman was a driving force in HIV drug development during the height of the AIDS crisis and went on to spearhead some of the agency’s most consequential initiatives. She launched the expedited drug development and breakthrough therapy designation programs, directed the Critical Path Initiative, guided establishment of the Oncology Center of Excellence, and was instrumental in advancing the Sentinel Initiative and the biosimilars regulatory framework. She oversaw medical programs with a budget of more than five hundred million dollars.

From Public Service to Private Sector Leadership

An internist with a subspecialty in infectious diseases, Sherman holds an MD from Mount Sinai School of Medicine, an MPH from Johns Hopkins University, and a BA in Mathematics from Washington University in St. Louis. She is currently President of Rachel Sherman Partners, LLC, and serves on multiple corporate boards and as faculty at Harvard University’s Department of Population Health.

Sherman delivers keynotes that provide insider perspectives on FDA regulation, healthcare policy, data quality, and the evolving landscape of medical innovation.

ALL OF DR SHERMAN’S SESSIONS ARE HIGHLY CUSTOMIZED AND DETAILED SESSION DESCRIPTIONS FOLLOW INITIAL BRIEFING AND BACKGROUND RESEARCH AND CLIENT PREEVENT CONFERENCE CALL

• Inside the FDA
• Analytics Data Quality Issues
• Building Effective Organizations
• Women in the Workplace
• Working Effectively with Government Agencies